Ceftriaxone in treatment of serious infections. Pneumonia and lower respiratory tract infections.

Abstract

One gram once daily of ceftriaxone is as effective as 2 gm for the common causative organisms of community-acquired and nosocomial pneumonias. It should not be used alone against L. pneumophila, the TWAR pneumoniae, and possibly anaerobic pathogens. Preliminary study suggests that a regimen of 500 mg a day may be effective in selected patients with simple pneumonias caused by sensitive pathogens. Ceftriaxone is safe, well tolerated, and cost-effective, which means it can play a significant therapeutic role in nursing homes and other long-term care facilities as well as in outpatient therapy.

• Authors: R Brown
• Journal: Hospital practice (Office ed.) (Hosp Pract (Off Ed)) Vol. 26 Suppl 5 Pg. 37-42; discussion 59-62 (Sep 1991) ISSN: 8750-2836 [Print] United States
• PMID: 1918221 (Publication Type: Journal Article, Review)

Chemical References

• Ceftriaxone

Topics

• Bacterial Infections (drug therapy)
• Ceftriaxone (administration & dosage, therapeutic use)
• Drug Administration Schedule
• Humans
• Pneumonia (drug therapy)
• Respiratory Tract Infections (drug therapy)